Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-016413
Filing Date
2022-08-17
Accepted
2022-08-17 17:06:57
Documents
1
Period of Report
2022-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5281
  Complete submission text file 0001567619-22-016413.txt   6796
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARCUTIS BIOTHERAPEUTICS, INC. 2945 TOWNSGATE ROAD, SUITE 110 WESTLAKE VILLAGE CA 91361
Business Address
Welgus Howard G. (Reporting) CIK: 0001801050 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39186 | Film No.: 221175122